TY - JOUR
KW - Assay systems
KW - Drug regulation
KW - Lab-on-a-chip
KW - Scientific community
KW - Tissue engineering
AU - David M. Stresser
AU - Anna K. Kopec
AU - Philip Hewitt
AU - Rhiannon N. Hardwick
AU - Terry R. Van Vleet
AU - Prathap Kumar S. Mahalingaiah
AU - Denice O’Connell
AU - Gary J. Jenkins
AU - Rhiannon David
AU - Jessica Graham
AU - Donna Lee
AU - Jason Ekert
AU - Aaron Fullerton
AU - Remi Villenave
AU - Piyush Bajaj
AU - James R. Gosset
AU - Sherry L. Ralston
AU - Manti Guha
AU - Alejandro Amador-Arjona
AU - Kainat Khan
AU - Saket Agarwal
AU - Catrin Hasselgren
AU - Xiaoting Wang
AU - Khary Adams
AU - Gaurav Kaushik
AU - Arkadiusz Raczynski
AU - Kimberly A. Homan
AB - Pharmaceutical companies continue to advocate for the use of in vitro models towards the reduction of animal use in drug discovery and development while acknowledging that further advancements are needed to heighten the models’ current state of readiness.
BT - Nature Biomedical Engineering
DA - 2023-12-27
DO - 10.1038/s41551-023-01154-7
LA - en
N2 - Pharmaceutical companies continue to advocate for the use of in vitro models towards the reduction of animal use in drug discovery and development while acknowledging that further advancements are needed to heighten the models’ current state of readiness.
PY - 2023
SP - 1
EP - 6
T2 - Nature Biomedical Engineering
TI - Towards in vitro models for reducing or replacing the use of animals in drug testing
UR - https://www.nature.com/articles/s41551-023-01154-7
Y2 - 2024-08-13
SN - 2157-846X
ER -